ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Set to Benefit From Novartis ASCO Data
|
|
Austonia
|
24 |
10K |
4 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
24
|
10K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Set to Benefit From Novartis ASCO Data
|
|
Austonia
|
24 |
10K |
6 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
24
|
10K
|
6
|
|
ASX - By Stock
|
XAM |
Re:
Ann: Gold-Rich High-Grade Zone extended at Kharmagtai
|
|
Austonia
|
62 |
18K |
0 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
62
|
18K
|
0
|
|
ASX - By Stock
|
XAM |
Re:
XAM Chart
|
|
Austonia
|
170 |
46K |
3 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
170
|
46K
|
3
|
|
ASX - By Stock
|
XAM |
Re:
XAM Chart
|
|
Austonia
|
170 |
46K |
0 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
170
|
46K
|
0
|
|
ASX - By Stock
|
XAM |
Re:
Ann: Gold-Rich High-Grade Zone extended at Kharmagtai
|
|
Austonia
|
62 |
18K |
5 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
62
|
18K
|
5
|
|
ASX - By Stock
|
XAM |
Re:
Ann: Gold-Rich High-Grade Zone extended at Kharmagtai
|
|
Austonia
|
62 |
18K |
4 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
62
|
18K
|
4
|
|
ASX - By Stock
|
XAM |
Re:
XAM Chart
|
|
Austonia
|
170 |
46K |
6 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
170
|
46K
|
6
|
|
ASX - By Stock
|
LBT |
Re:
fda news pending
|
|
Austonia
|
61 |
22K |
0 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
61
|
22K
|
0
|
|
ASX - By Stock
|
LBT |
Re:
fda news pending
|
|
Austonia
|
61 |
22K |
0 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
61
|
22K
|
0
|
|
ASX - By Stock
|
LBT |
Re:
fda news pending
|
|
Austonia
|
61 |
22K |
0 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
61
|
22K
|
0
|
|
ASX - By Stock
|
LBT |
Re:
fda news pending
|
|
Austonia
|
61 |
22K |
4 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
61
|
22K
|
4
|
|
ASX - By Stock
|
LBT |
Re:
fda news pending
|
|
Austonia
|
61 |
22K |
9 |
13/01/21 |
13/01/21 |
ASX - By Stock
|
61
|
22K
|
9
|
|
ASX - By Stock
|
LBT |
Re:
fda news pending
|
|
Austonia
|
61 |
22K |
3 |
12/01/21 |
12/01/21 |
ASX - By Stock
|
61
|
22K
|
3
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Update on MRSA Analysis Module US FDA Submission
|
|
Austonia
|
17 |
9.0K |
2 |
04/01/21 |
04/01/21 |
ASX - By Stock
|
17
|
9.0K
|
2
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Market Update - EU Commercial Activities
|
|
Austonia
|
29 |
8.7K |
5 |
22/12/20 |
22/12/20 |
ASX - By Stock
|
29
|
8.7K
|
5
|
|